HOWL Q4 2022 Earnings — Werewolf Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HOWLWerewolf Therapeutics, Inc.

$35M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M

Gross Profit

-$6M-79.2% margin

Operating Income

-$13M-181.0% margin

Net Income

-$12M-163.8% margin

EPS (Diluted)

$-0.35

QoQ Revenue Growth

+46.5%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$160M

Total Liabilities

$38M

Stockholders' Equity

$122M

Cash & Equivalents

$129M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$0	—
Gross Profit	-$6M	$0	—
Operating Income	-$13M	-$18M	+26.3%
Net Income	-$12M	-$18M	+33.2%